The Effect of Continuous Epidural Analgesia on Intracranial Pressure by Measuring the Optic Nerve Sheath Diameter Using Ultrasound in Pediatric Patients
1 other identifier
interventional
60
1 country
1
Brief Summary
Ultrasonography of optic nerve sheath diameter shows a good level of diagnostic accuracy for detecting intracranial hypertension. The aim of this study is to evaluate the effect of continuous epidural block on intracranial pressure in pediatric patients undergoing osteotomy of lower extremity. Forty patients, aged 4 years to 13 years, receiving epidural analgesia before osteotomy will be divided into bolus group (n=30) and infusion group (n=30). Randomly selected patients of the bolus group are given 0.3 ml/kg bolus/hr of 0.15% ropivacaine for epidural analgesia. In contrast, patients in the infusion group are administered 0.3 ml/kg/hr 0.15% ropivacaine at a constant rate for epidural analgesia. The primary endpoint is the difference in the optic nerve sheath diameter after epidural analgesia measured by optic nerve ultrasonography between groups.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Apr 2019
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2019
CompletedFirst Submitted
Initial submission to the registry
April 9, 2019
CompletedFirst Posted
Study publicly available on registry
April 11, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2021
CompletedApril 11, 2019
April 1, 2019
1.9 years
April 9, 2019
April 9, 2019
Conditions
Outcome Measures
Primary Outcomes (6)
The difference in the optic nerve sheath diameter (ONSD) between groups
The optic nerve sheath diameter measured by optic nerve ultrasonography
Before epidural block
The difference in the optic nerve sheath diameter (ONSD) between groups
The optic nerve sheath diameter measured by optic nerve ultrasonography
30 minutes after epidural block
The difference in the optic nerve sheath diameter (ONSD) between groups
The optic nerve sheath diameter measured by optic nerve ultrasonography
60 minutes after epidural block
The difference in the optic nerve sheath diameter (ONSD) between groups
The optic nerve sheath diameter measured by optic nerve ultrasonography
90 minutes after epidural block
The difference in the optic nerve sheath diameter (ONSD) between groups
The optic nerve sheath diameter measured by optic nerve ultrasonography
120 minutes after epidural block
The difference in the optic nerve sheath diameter (ONSD) between groups
The optic nerve sheath diameter measured by optic nerve ultrasonography
180 minutes after epidural block
Secondary Outcomes (6)
The difference in the number of patients whose ONSD values increased to more than 5.75 mm at each time point between the two groups
Before epidural block
The difference in the number of patients whose ONSD values increased to more than 5.75 mm at each time point between the two groups
30 minutes after epidural block
The difference in the number of patients whose ONSD values increased to more than 5.75 mm at each time point between the two groups
60 minutes after epidural block
The difference in the number of patients whose ONSD values increased to more than 5.75 mm at each time point between the two groups
90 minutes after epidural block
The difference in the number of patients whose ONSD values increased to more than 5.75 mm at each time point between the two groups
120 minutes after epidural block
- +1 more secondary outcomes
Study Arms (2)
Bolus group
EXPERIMENTALInfusion group
ACTIVE COMPARATORInterventions
Randomly selected patients of the bolus group are given 0.3 ml/kg bolus/hr of 0.15% ropivacaine for epidural analgesia. In contrast, patients in the infusion group are administered 0.3 ml/kg/hr 0.15% ropivacaine at a constant rate for epidural analgesia.
Eligibility Criteria
You may qualify if:
- \. Pediatric patients from 4 to 13 years of age undergoing osteotomy of lower extremity
You may not qualify if:
- \. Patients with contraindications to epidural analgesia (local infection, clotting disorders, anatomical abnormalities, sepsis, etc.)
- \. Patients with symptoms or signs associated with a history of elevated intracranial pressure or elevated intracranial pressure
- \. Patients with ophthalmic disease or surgery
- \. The estimated operation time is less than 180 minutes.
- \. All parents of the subject are foreigners or illiterate
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Anesthesiology and Pain Medicine, Anesthesia and Pain Research Institue, Yonsei Universiy College of Medicine
Seoul, 03722, South Korea
Related Publications (2)
Lin Y, Li Q, Liu J, Yang R, Liu J. Comparison of continuous epidural infusion and programmed intermittent epidural bolus in labor analgesia. Ther Clin Risk Manag. 2016 Jul 14;12:1107-12. doi: 10.2147/TCRM.S106021. eCollection 2016.
PMID: 27471390BACKGROUNDPadayachy LC, Padayachy V, Galal U, Pollock T, Fieggen AG. The relationship between transorbital ultrasound measurement of the optic nerve sheath diameter (ONSD) and invasively measured ICP in children. : Part II: age-related ONSD cut-off values and patency of the anterior fontanelle. Childs Nerv Syst. 2016 Oct;32(10):1779-85. doi: 10.1007/s00381-016-3068-4. Epub 2016 Sep 20.
PMID: 27659820BACKGROUND
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR
- Masking Details
- Participants, care providers and investigators are blinded to group assignment.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 9, 2019
First Posted
April 11, 2019
Study Start
April 1, 2019
Primary Completion
March 1, 2021
Study Completion
March 1, 2021
Last Updated
April 11, 2019
Record last verified: 2019-04